Drug – bio-affecting and body treating compositions – Antigen – epitope – or other immunospecific immunoeffector – Recombinant or stably-transformed bacterium encoding one or...
Patent
1976-05-10
1978-05-02
Meyers, Albert T.
Drug, bio-affecting and body treating compositions
Antigen, epitope, or other immunospecific immunoeffector
Recombinant or stably-transformed bacterium encoding one or...
424 12, A61K 31185
Patent
active
040875482
ABSTRACT:
C-substituted trisulfonic acids, acid ureides, oxalyl amides and salts thereof useful as complement inhibitors.
REFERENCES:
patent: 3897434 (1975-07-01), Katner
patent: 3903106 (1975-09-01), Katner
Fourneau, Ann. Inst. Pasteur, vol. 38, 1924 pp. 81-114.
Adams, J. Chem Soc (London), Part III, 1956 pp. 3739-3744.
Wills, The Biochem J, vol. 47, 1950 pp. 158-170.
Fong, Clin. Exp. Immunol. vol. 10, 1972 pp. 127-138.
Mayer, Sci American, vol. 229, Nov. 1973 pp. 54-66.
Bergamini, Chem Abs. vol. 43, 1949 p. 3855 ghi.
Bernstein Seymour
Lenhard Robert Herman
American Cyanamid Company
Fagelson A. P.
Meyers Albert T.
Richards Jack W.
LandOfFree
Complement inhibitors does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Complement inhibitors, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Complement inhibitors will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2158869